Navigation Links
Exploiting the architecture of cancers may lead to their destruction
Date:3/10/2010

After making a diagnosis of cancer, clinicians have a number of treatment options. Most of these involve coordinating multiple attacks on the tumor using an arsenal of cancer-killing therapies. Chemotherapy, where toxic drugs are used to specifically kill cancer cells, is a very powerful weapon in this arsenal. It is extremely effective in treating some cancers, such as testicular cancer and Hodgkin's Disease, but works poorly in other cancer types. Although the reasons for these different responses are complex, one of the known limitations for solid tumors is that sometimes killer drugs injected into the bloodstream are not delivered efficiently to the tumor tissue, and even if they do reach their target, are not retained long enough to administer their lethal hit.

Professor Lisa Coussens and her coworkers, based at the University of California San Francisco Medical Center, have now discovered a way of enhancing drug delivery to tumors: using the cancer's own architecture to bring about its downfall. Solid tumors need a good blood supply in order to grow, and the blood vessels nourishing the tumors are frequently disorganized and leaky, allowing drugs to leach into the tumor. However, this useful property is counteracted by high tissue pressure within the tumor itself, which creates a barrier for drug uptake. Coussens' team have found a way of tipping the balance in favor of the blood vessels. Using a mouse model of cancer, they show that blocking the action of a signaling molecule called ALK5 makes tumor blood vessels even leakier for a short period of time, and this window of leakiness can be used to "open up" the tumor for more efficient delivery of drugs.

Coussens' discovery has exciting implications. Blocking the ALK5 pathway may not only make chemotherapy far more effective in multiple cancers, but could also aid in efficient delivery of the many other therapies that rely on the bloodstream to carry them into a tumor. Further, ALK5 blo
'/>"/>

Contact: Kristy Kain
kristy.kain@vanderbilt.edu
615-343-1298
The Company of Biologists
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New Film Exposes Bruce Wasserstein and Lazard-linked Elderly Care Facilities Exploiting Seniors
2. EwingCole, RDLA Join Together, Creating Architecture/Engineering Firm With Largest Healthcare Focus in the Delaware Valley
3. MedTrust Online Completes Second Round of Financing, Releases Next Generation Search Engine for Oncology Utilizing Dell eHealthcare Architecture Framework
4. Edmond Scientific Company Awarded VA Contract for External Integration Architecture Support
5. Health Level Seven and The Health Story Project Announce Publication of Diagnostic Imaging Report Guide at Annual RSNA Meeting : HL7 Clinical Document Architecture (CDA) Implementation Guide Enhances Radiology Reporting
6. Experts, Advocates Tackle Challenges of Autism, Architecture
7. Sonoma Developer Oakmount Senior Living Marries Architecture With Nature to Recreate Tuscany at Varenna
8. AP-HM Places Patients at the Core of its Service-Oriented Architecture with BEA Systems
9. Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium
10. Herceptin and Tykerb effective against a subset of gastric cancers
11. Proton beam therapy shows encouraging long-term outcome for patients with locally advanced sinonasal cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014 Officials with OZ Naturals ... in the UK in September. , Craig Romero, CEO of ... Sept. 7 on Amazon.co.uk. , “Demand for OZ Naturals products ... are truly looking forward to serving the European market,” Romero ... bestselling Vitamin C serum and hyaluronic acid ...
(Date:7/29/2014)... Regents Health Resources, a consulting firm traditionally specializing ... industry veteran Daryl Demonbreun and former St. Thomas executive ... ambitious plans to grow into a full-service health care ... at a steady pace for nearly 20 years, but ... Bob Maier, founder and chief executive officer of Regents ...
(Date:7/29/2014)... 29, 2014 Intermedix Corporation is proud ... Data eXchange. , The Clinical Data eXchange, or CDX, ... pre-hospital patient care data. , With this solution, state ... accept imports of NEMSIS 3.0 compliant data from multiple ... to be accessed, analyzed, and reported to the national ...
(Date:7/29/2014)... There is controversy over how best to treat patients ... one wait until the cancer comes back or provide ... Now, a new study from Thomas Jefferson ... doctors and patients make a more informed decision. , ... says first author Robert Den, M.D., Assistant Professor of ...
(Date:7/29/2014)... procedure may enable more widespread use of preoperative testing ... with severe sleep apnea, suggests a study in ... and Dr. Jeff E. Mandel of the University of ... control" anesthetic technique for putting patients to sleep briefly-just ... apnea. The simplified technique requires no special expertise and ...
Breaking Medicine News(10 mins):Health News:OZ Naturals to Launch Its Products in the UK 2Health News:Sferrella and Demonbruen Join Regents Health Resources 2Health News:Intermedix Releases NEMSIS Compliant EMS Information System 2Health News:Genomic analysis of prostate cancer indicates best course of action after surgery 2Health News:New anesthesia technique helps show cause of obstruction in sleep apnea 2Health News:New anesthesia technique helps show cause of obstruction in sleep apnea 3
... By Serena Gordon HealthDay Reporter , WEDNESDAY, Dec. ... the drug Avastin may lengthen progression-free survival by about four ... yet is whether adding Avastin (bevacizumab) will make a difference ... other study didn,t find a difference in overall survival between ...
... 28, 2011. The 2011 revision of the International Standards ... was published in the November 2011 issue of the ... reference article by Steven Kirshblum et al clarifies the ... free download via http://www.ingentaconnect.com/content/maney/scm (#6, Nov 2011). ...
... Treating ovarian cancer with the drug bevacizumab ("Avastin") delays the ... an international clinical trial co-led by Drs. Amit Oza of ... Perren, St James,s Institute of Oncology, Leeds, UK. ... of Medicine, report that the drug halted the cancer,s ...
... Goodwin HealthDay Reporter , WEDNESDAY, Dec. 28 (HealthDay ... acids and vitamins B, C, D and E in their ... also tended to have larger brain volume, a new study ... their blood fared worse on certain thinking tests than those ...
... News) -- A new examination of the origin of syphilis ... to Europe aboard Christopher Columbus, ships as they sailed ... not spread through sexual contact at the time, but adapted ... say. "Syphilis has been around for 500 years," ...
... , WEDNESDAY, Dec. 28 (HealthDay News) -- Knowing ... may lead to an early diagnosis, experts say. According ... Plan ahead for the future. , Potentially take part ... help maintain independence for a longer time and possibly improve ...
Cached Medicine News:Health News:Avastin May Help Some With Ovarian Cancer: Studies 2Health News:Avastin May Help Some With Ovarian Cancer: Studies 3Health News:Avastin May Help Some With Ovarian Cancer: Studies 4Health News:JSCM publishes revised International Standards for Neurological Classification of Spinal Cord Injury 2Health News:Ovarian cancer study proves drug delays disease progression, may improve survival 2Health News:Vitamins, Omega-3s May Keep Brain From Shrinking: Study 2Health News:Vitamins, Omega-3s May Keep Brain From Shrinking: Study 3Health News:Columbus Voyage Tied to Syphilis Spread? 2Health News:Know the Signs of Alzheimer's 2
(Date:7/28/2014)... FRANCISCO , July 28, 2014  Dignity ... it has received the Get With The Guidelines®-Stroke ... improvement measures outlined by the American Heart Association/American ... Stroke is the number four cause of death ... the United States , according ...
(Date:7/28/2014)... Calif. , July 28, 2014 STAAR ... developer, manufacturer and marketer of implantable lenses and delivery ... its second quarter results and conference call with investors ... July 30, 2014.  The Company rescheduled the release date ... the funeral services for Hideo Watanabe , President ...
(Date:7/28/2014)... July 28, 2014  MiMedx Group, Inc. (NASDAQ: MDXG ... regenerative biomaterials and bioimplants processed from human amniotic membrane, announced ... Highlights include: , Revenue exceeds ... 2013 to $25.6 million , Quarter-over-quarter ... Care revenue increases 181% over Q2 2013 and 40% sequentially ...
Breaking Medicine Technology:Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3STAAR Surgical Moves Second Quarter Earnings Release and Conference Call One Day to July 31 2MiMedx Announces Record Second Quarter Results 2MiMedx Announces Record Second Quarter Results 3MiMedx Announces Record Second Quarter Results 4MiMedx Announces Record Second Quarter Results 5MiMedx Announces Record Second Quarter Results 6MiMedx Announces Record Second Quarter Results 7MiMedx Announces Record Second Quarter Results 8MiMedx Announces Record Second Quarter Results 9MiMedx Announces Record Second Quarter Results 10MiMedx Announces Record Second Quarter Results 11MiMedx Announces Record Second Quarter Results 12MiMedx Announces Record Second Quarter Results 13MiMedx Announces Record Second Quarter Results 14MiMedx Announces Record Second Quarter Results 15MiMedx Announces Record Second Quarter Results 16MiMedx Announces Record Second Quarter Results 17MiMedx Announces Record Second Quarter Results 18
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: